Followers | 898 |
Posts | 148967 |
Boards Moderated | 0 |
Alias Born | 08/13/2010 |
Friday, June 24, 2016 11:35:10 AM
$AMRS "Amyris is developing cost-effective and sustainably produced natural oils and aroma chemicals commonly used in the Flavors and Fragrances (F&F) market.
Many of the natural ingredients used in F&F are expensive because there is limited supply and the synthetic alternatives require complex chemical conversions.
Utilizing our biotechnology platform and industrial fermentation processes, we convert plant sugars into cost-effective, sustainable F&F ingredients. By sourcing multiple sugar feedstocks we decouple our production process from the price and supply volatility of natural oils and petroleum, allowing us to produce ingredients reliably and at scale.
We are focused on delivering value in three key areas of the F&F industry:
Providing an alternative, reliable, and cost-effective supply of well-known and highly sought-after ingredients which suffer from pricing, availability or sustainability concerns;
Creating new “building blocks” from which novel and cost-effective ingredients can be developed; and,
Developing new and unique ingredients for our partners to be used directly in fragrance and flavor compounds.
Amyris is currently working with Firmenich, IFF and Givaudan, some of the world’s largest F&F groups, to bring multiple products to market resulting in creative new aromas and tastes for the consumer to enjoy."
https://amyris.com/products/flavors-fragrances/
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Recent AMRSQ News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:39 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/10/2024 02:24:29 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/10/2024 02:14:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:42:49 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/14/2023 09:34:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:23:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:43:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM